症状科学模型在慢性病护理中的应用进展及启示

doi:10.3761/j.issn.0254-1769.2023.06.016

摘要/Abstract

摘要：

症状科学模型整合4个核心要素（复杂症状、表型特征、生物行为因素、临床应用）和3个影响因素（以患者为中心的体验、健康的社会决定因素、政策与人口健康），探索慢性病的症状评估、生物学机制及管理。症状科学模型强调基因组学、蛋白组学、微生物组学、代谢组学等方法在症状科学研究中的重要作用，促进护士对症状潜在生物学机制和生物标志物的理解，并开发具有针对性的、成本效益的、创新性的干预和控制措施，以预防、管理或改善慢性病的症状。该研究描述了症状科学模型的形成、框架，分析了症状科学模型在慢性病护理中的应用现状，为慢性病症状管理中的多学科融合发展提供借鉴。

关键词: 症状科学模型, 慢性病护理, 生物学机制, 护理, 综述

Abstract:

The symptom science model integrates 4 core elements （complex symptom，phenotype characterization，biobehavioral factors，and clinical application） and 3 influencing factors（patient-centered experience，social determinants of health，policy and population health） to explore the symptom assessment，biological mechanisms and management of chronic diseases. The symptom science model emphasizes the important role of genomics，proteomics，microbiomics，and metabolomics and other methods in the study of symptom science，promotes nurses’ understanding of the potential biological mechanisms and biomarkers of symptoms，and develops targeted，cost-effective and innovative interventions and control measures to prevent，manage or improve the symptoms of chronic diseases. This study describes the formation and framework of symptom science model，analyses the application status of symptom science model in chronic disease nursing care，and provides references for multidisciplinary integration development in chronic disease symptom management.

Key words: Symptom Science Model, Chronic Disease Nursing, Biological Mechanism, Nursing Care, Review

陈东亮, 王媛飞, 陆晓敏, 曾泽, 陈祖敏, 林琛莅, 梁荫基. 症状科学模型在慢性病护理中的应用进展及启示[J]. 中华护理杂志, 2023, 58(6): 751-757.

CHEN Dongliang, WANG Yuanfei, LU Xiaomin, ZENG Ze, CHEN Zumin, LIN Chenli, LIANG Yinji. Application progress and enlightenment of symptom science model in chronic disease nursing care[J]. Chinese Journal of Nursing, 2023, 58(6): 751-757.

图/表 4

表1 症状科学模型在癌症相关症状研究中的应用

Table 1 Application of SSM in studies of cancer related symptoms

表2 症状科学模型在精神疾病相关症状研究中的应用

Table 2 Application of SSM in studies of mental illness related symptoms

表3 症状科学模型在心血管疾病相关症状研究中的应用

Table 3 Application of SSM in studies of cardiovascular disease related symptoms

表4 症状科学模型在代谢性疾病相关症状研究中的应用

Table 4 Application of SSM in studies of metabolic disease related symptoms

参考文献 39

[1]	Rhodes VA. Symptom distress—the concept:past and present[J]. Semin Oncol Nurs, 1987, 3(4):242-247. PMID
[2]	Cashion AK. The national institutes of health/national institutes of nursing research intramural research program and the development of the national institutes of health symptom science model[J]. Nurs Outlook, 2015, 63(4):484-487. DOI PMID
[3]	Kurnat-Thoma EL, Graves LY, Billones RR. A concept development for the symptom science model 2.0[J]. Nurs Res, 2022, 71(6):48-60.
[4]	Cashion AK, Gill J, Hawes R, et al. National institutes of health symptom science model sheds light on patient symptoms[J]. Nurs Outlook, 2016, 64(5):499-506. DOI PMID
[5]	Engler MB, Austin JK, Grady P. The national institute of nursing research graduate partnerships program(ninr-gpp):an opportu-nity for PHD students[J]. Nurs Outlook, 2014, 62(6):469-474. DOI PMID
[6]	Hickey KT, Bakken S, Byrne MW, et al. Precision health:advancing symptom and self-management science[J]. Nurs Outlook, 2019, 67(4):462-475. DOI URL
[7]	Ferranti EP, Grossmann R, Starkweather A, et al. Biological determinants of health:genes,microbes,and metabolism exemplars of nursing science[J]. Nurs Outlook, 2017, 65(5):506-514. DOI PMID
[8]	臧瑜, 于虹, 李妍, 等. 肺癌患者症状群的调查研究[J]. 中华护理杂志, 2016, 51(3):316-320.
	Zang Y, Yu H, Li Y, et al. A study of symptom clusters in patients with lung cancer[J]. Chin J Nurs, 2016, 51(3):316-320.
[9]	Kim SH, Song YK, Han J, et al. Erratum:pro-inflammatory cytokine levels and cancer-related fatigue in breast cancer survivors:effects of an exercise adherence program[J]. J Breast Cancer, 2020, 23(5):574-575. DOI URL
[10]	Hajj A, Chamoun R, Salameh P, et al. Fatigue in breast cancer patients on chemotherapy:a cross-sectional study exploring clinical,biological,and genetic factors[J]. BMC Cancer, 2022, 22(1):16. DOI
[11]	Hsiao CP, Daly B, Chen MK, et al. Possible bioenergetic biomarker for chronic cancer-related fatigue[J]. Nurs Res, 2021, 70(6):475-480. DOI URL
[12]	Feng LR, Barb JJ, Allen H, et al. Steroid hormone biosynthesis metabolism is associated with fatigue related to androgen deprivation therapy for prostate cancer[J]. Front Cell Dev Biol, 2021, 9:642307. DOI URL
[13]	Kwekkeboom KL, Tostrud L, Costanzo E, et al. The role of inflammation in the pain,fatigue,and sleep disturbance symptom cluster in advanced cancer[J]. J Pain Symptom Manage, 2018, 55(5):1286-1295. DOI URL
[14]	Chou YJ, Kober KM, Kuo CH, et al. A pilot study of metabolomic pathways associated with fatigue in survivors of colorectal cancer[J]. Biol Res Nurs, 2021, 23(1):42-49. DOI URL
[15]	Chou YJ, Kober KM, Yeh KH, et al. A pilot study of metabolomic pathways associated with fatigue in patients with colorectal cancer receiving chemotherapy[J]. Eur J Oncol Nurs, 2022, 56:102096. DOI URL
[16]	Portelius E, Zetterberg H, Skillbäck T, et al. Cerebrospinal fluid neurogranin:relation to cognition and neurodegeneration in alzheimer’s disease[J]. Brain, 2015, 138(Pt 11):3373-3385. DOI PMID
[17]	Dakterzada F, David Benítez I, Targa A, et al. Reduced levels of mir-342-5p in plasma are associated with worse cognitive evolution in patients with mild alzheimer’s disease[J]. Front Aging Neurosci, 2021, 13:705989. DOI URL
[18]	Xie B, Liu ZC, Jiang L, et al. Increased serum mir-206 level predicts conversion from amnestic mild cognitive impairment to alzheimer’s disease:a 5-year follow-up study[J]. J Alzheimers Dis, 2017, 55(2):509-520. DOI URL
[19]	Seddighi S, Varma VR, An Y, et al. Sparcl1 accelerates symptom onset in alzheimer’s disease and influences brain structure and function during aging[J]. J Alzheimers Dis, 2018, 61(1):401-414. DOI PMID
[20]	Felger JC, Haroon E, Patel TA, et al. What does plasma crp tell us about peripheral and central inflammation in depression?[J]. Mol Psychiatry, 2020, 25(6):1301-1311. DOI
[21]	Strawbridge R, Marwood L, King S, et al. Inflammatory proteins and clinical response to psychological therapy in patients with depression:an exploratory study[J]. J Clin Med, 2020, 9(12):3918. DOI URL
[22]	Zhou XY, Liu LX, Lan XH, et al. Polyunsaturated fatty acids metabolism,purine metabolism and inosine as potential independent diagnostic biomarkers for major depressive disorder in children and adolescents[J]. Mol Psychiatry, 2019, 24(10):1478-1488. DOI
[23]	郑改改, 杨巧芳, 殷月, 等. 急性心力衰竭患者入院时及易损期核心症状群的纵向研究[J]. 中华护理杂志, 2022, 57(17):2109-2115. DOI
	Zheng GG, Yang QF, Yin Y, et al. The changes of core symptom clusters in patients with acute heart failure during admission and vulnerable phase:a longitudinal study[J]. Chin J Nurs, 2022, 57(17):2109-2115.
[24]	Brandt J, Warnke K, Jörgens S, et al. Association of fkbp5 genotype with depressive symptoms in patients with coronary heart disease:a prospective study[J]. J Neural Transm(Vienna), 2020, 127(12):1651-1662.
[25]	Mirzaei S, Burke L, Rosenfeld AG, et al. Protein cytokines,cytokine gene polymorphisms,and potential acute coronary syndrome symptoms[J]. Biol Res Nurs, 2019, 21(5):552-563. DOI URL
[26]	Pierce JD, Mahoney DE, Hiebert JB, et al. Study protocol,randomized controlled trial:reducing symptom burden in patients with heart failure with preserved ejection fraction using ubiquinol and/or d-ribose[J]. BMC Cardiovasc Disord, 2018, 18(1):57. DOI
[27]	Denfeld QE, Camacho SA, Dieckmann N, et al. Background and design of the biological and physiological mechanisms of symptom clusters in heart failure(biomes-hf) study[J]. J Card Fail, 2022, 28(6):973-981. DOI URL
[28]	Liang YJ, Zou LL, Tian YL, et al. Dietary and metabolic risk of neuropsychiatric disorders:insights from animal models[J]. Br J Nutr, 2021, 126(12):1771-1787. DOI URL
[29]	Herder C, Fürstos JF, Nowotny B, et al. Associations between inflammation-related biomarkers and depressive symptoms in individuals with recently diagnosed type 1 and type 2 diabetes[J]. Brain Behav Immun, 2017, 61:137-145. DOI PMID
[30]	Herder C, Schmitt A, Budden F, et al. Longitudinal associations between biomarkers of inflammation and changes in depressive symptoms in patients with type 1 and type 2 diabetes[J]. Psychoneuroendocrinology, 2018, 91:216-225. DOI PMID
[31]	Zheng TP, Ge B, Qin LY, et al. Association of plasma dpp4 activity and brain-derived neurotrophic factor with moderate to severe depressive symptoms in patients with type 2 diabetes:results from a cross-sectional study[J]. Psychosom Med, 2020, 82(4):350-358. DOI URL
[32]	Radford-Smith DE, Patel PJ, Irvine KM, et al. Depressive symptoms in non-alcoholic fatty liver disease are identified by perturbed lipid and lipoprotein metabolism[J]. PLoS One, 2022, 17(1):e0261555. DOI URL
[33]	An K, Starkweather A, Sturgill J, et al. Association of ctrp13 with liver enzymes and cognitive symptoms in nonalcoholic fatty liver disease[J]. Nurs Res, 2019, 68(1):29-38. DOI PMID
[34]	Harris CS, Miaskowski CA, Dhruva AA, et al. Multi-staged data-integrated multi-omics analysis for symptom science research[J]. Biol Res Nurs, 2021, 23(4):596-607. DOI URL
[35]	Tallon E, Dreisbach C. Using data science to understand complexity and quantify heterogeneity in the onset and progression of chronic disease[J]. Biol Res Nurs, 2019, 21(5):449-457. DOI PMID
[36]	Tripp-Reimer T, Williams JK, Gardner SE, et al. An integrated model of multimorbidity and symptom science[J]. Nurs Outlook, 2020, 68(4):430-439. DOI PMID
[37]	Henly SJ, McCarthy DO, Wyman JF, et al. Emerging areas of science:recommendations for nursing science education from the council for the advancement of nursing science idea festival[J]. Nurs Outlook, 2015, 63(4):398-407. DOI URL
[38]	Fu Mei.R., 田亚丽, 胡秀英, 等. 精准护理的应用领域及发展方向[J]. 中华护理杂志, 2017, 52(10):1273-1275.
	Fu MR, Tian YL, Hu XY, et al. Precision nursing:trend and implication[J]. Chin J Nurs, 2017, 52(10):1273-1275.
[39]	Fu MR, Kurnat-Thoma E, Starkweather A, et al. Precision health:a nursing perspective[J]. Int J Nurs Sci, 2020, 7(1):5-12.